ReviewRheumatology international2026
Teaching evidence-based principles in Rheumatology.
Review in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence-based medicine (EBM) integrates the best available evidence with clinical expertise and patients’ values and preferences to support high-quality, patient-centered care. While early EBM education emphasized critical appraisal of primary studies, it has progressively shifted toward a pragmatic approach that prioritizes the use of evidence summaries to enable timely, informed clinical decisions. Accordingly, EBM training may benefit from an emphasis on developing skills related to interpreting effect sizes, appreciating the certainty of the evidence, understanding the strength of recommendations, and applying research findings in clinical contexts through shared decision-making. This evolution reflects the realities of contemporary healthcare, in which time constraints and the exponential growth of the medical literature limit the feasibility of relying on individual studies for routine clinical decision-making. In Rheumatology, these competencies are particularly important for selecting synthetic or biologic disease-modifying antirheumatic drugs or targeted therapies, and for diagnostic decisions involving classification criteria, imaging, and biomarkers, where the certainty of evidence often varies. Moreover, rheumatology practice relies heavily on clinical practice guidelines that frequently issue conditional recommendations, underscoring the need to contextualize evidence in light of patient preferences, comorbidities, and treatment burden.
Indexed as
Identifiers
41746359What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.